Hca Healthcare ( (HCA) ) has released its Q4 earnings. Here is a breakdown of the information Hca Healthcare presented to its investors.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
HCA Healthcare, Inc., a leading healthcare provider operating hospitals and ambulatory sites in the U.S. and the U.K., has released its fourth-quarter 2024 financial results, highlighting a year of significant growth and operational resilience despite challenges.
For the fourth quarter, HCA Healthcare reported revenues of $18.285 billion, marking an increase from the previous year. However, net income saw a decline to $1.438 billion, attributed partly to the financial impact from Hurricanes Helene and Milton. The company’s adjusted EBITDA showed a positive trend, rising to $3.712 billion, reflecting solid business fundamentals and operational improvements.
Key performance indicators for the quarter included a 3.0% increase in same-facility admissions and a 2.9% increase in same-facility revenue per equivalent admission. Despite a slight decline in outpatient surgeries, inpatient surgeries and emergency room visits showed growth. Additionally, the company announced a $10 billion share repurchase authorization and declared a quarterly dividend of $0.72 per share.
Looking ahead, HCA Healthcare has provided guidance for 2025, projecting revenues between $72.80 billion and $75.80 billion and an adjusted EBITDA range of $14.30 billion to $15.10 billion. The company anticipates continued volume growth and a stable operating environment, although it acknowledges potential ongoing impacts from recent hurricanes and broader economic conditions.
